Topical Application of St. Johnʼs Wort (Hypericum perforatum)

St. John's wort (Hypericum perforatum) has been intensively investigated for its antidepressive activity, but dermatological applications also have a long tradition. Topical St. John's wort preparations such as oils or tinctures are used for the treatment of minor wounds and burns, sunburns, abrasions, bruises, contusions, ulcers, myalgia, and many others. Pharmacological research supports the use in these fields. Of the constituents, naphthodianthrones (e.g., hypericin) and phloroglucinols (e.g., hyperforin) have interesting pharmacological profiles, including antioxidant, anti-inflammatory, anticancer, and antimicrobial activities. In addition, hyperforin stimulates growth and differentiation of keratinocytes, and hypericin is a photosensitizer which can be used for selective treatment of nonmelanoma skin cancer. However, clinical research in this field is still scarce. Recently, sporadic trials have been conducted in wound healing, atopic dermatitis, psoriasis, and herpes simplex infections, partly with purified single constituents and modern dermatological formulations. St. John's wort also has a potential for use in medical skin care. Composition and stability of pharmaceutical formulations vary greatly depending on origin of the plant material, production method, lipophilicity of solvents, and storage conditions, and this must be regarded with respect to practical as well as scientific purposes.

[1]  G. Schneider,et al.  Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo , 2009, Cellular and Molecular Life Sciences.

[2]  L. Maes,et al.  Assessment of antimicrobial and antiprotozoal activity of the olive oil macerate samples of Hypericum perforatum and their LC-DAD-MS analyses. , 2013, Food chemistry.

[3]  L. Verotta,et al.  Hyperforin analogues from St. John's wort (Hypericum perforatum). , 2000, Journal of natural products.

[4]  S. Vittori,et al.  Antimicrobial activity of seven hypericum entities from central Italy. , 2007, Planta medica.

[5]  Walter E. Müller,et al.  Specific TRPC6 Channel Activation, a Novel Approach to Stimulate Keratinocyte Differentiation* , 2008, Journal of Biological Chemistry.

[6]  L. M. Neves,et al.  Effects of microcurrent application alone or in combination with topical Hypericum perforatum L. and Arnica montana L. on surgically induced wound healing in Wistar rats , 2012, Homeopathy.

[7]  I. Takahashi,et al.  Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. , 1989, Biochemical and biophysical research communications.

[8]  K. Dietz,et al.  In Vitro Comparison of Hypericin and 5-Aminolevulinic Acid-Derived Protoporphyrin IX for Photodynamic Inactivation of Medulloblastoma Cells , 2012, PloS one.

[9]  V. Tadić,et al.  Estimation of Dermatological Application of Creams with St. John’s Wort Oil Extracts , 2011, Molecules.

[10]  P. Fedoročko,et al.  The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells. , 2012, Journal of photochemistry and photobiology. B, Biology.

[11]  R. Verpoorte,et al.  Evaluation of in-vivo wound healing activity of Hypericum patulum (Family: hypericaceae) leaf extract on different wound model in rats. , 2000, Journal of ethnopharmacology.

[12]  R. Saller,et al.  A homeopathic remedy from arnica, marigold, St. John’s wort and comfrey accelerates in vitro wound scratch closure of NIH 3T3 fibroblasts , 2012, BMC Complementary and Alternative Medicine.

[13]  Oliver Werz,et al.  Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. , 2002, Biochemical pharmacology.

[14]  R. Saller,et al.  Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  Mansoor M Ahmed,et al.  Efficacy and tolerability assessment of a topical formulation containing copper sulfate and hypericum perforatum on patients with herpes skin lesions: a comparative, randomized controlled trial. , 2012, Journal of drugs in dermatology : JDD.

[16]  L. French,et al.  Post-surgical scalp wounds with exposed bone treated with a plant-derived wound therapeutic. , 2012, Journal of wound care.

[17]  G. Nikolić,et al.  Treatment of Venous Ulcers with the Herbal-Based Ointment Herbadermal®: A Prospective Non-Randomized Pilot Study , 2012, Complementary Medicine Research.

[18]  J. Simon,et al.  Hypericin photo‐induced apoptosis involves the tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) and activation of caspase‐8 , 2001, FEBS letters.

[19]  C. Toniolo,et al.  Hypericum perforatum L. subsp. perforatum induces inhibition of free radicals and enhanced phototoxicity in human melanoma cells under ultraviolet light , 2013, Cell proliferation.

[20]  Talat Khadivzadeh,et al.  The effect of Hypericum perforatum on the wound healing and scar of cesarean. , 2010, Journal of alternative and complementary medicine.

[21]  S. Chung,et al.  Inhibition of Interleukin-12 Production in Lipopolysaccharide-Activated Mouse Macrophages by Hpyericin, an Active Component of Hypericum perforatum , 2001, Planta Medica.

[22]  Andrew W Bartlow,et al.  Medical Attributes of St. John’s Wort (Hypericum perforatum) , 2011 .

[23]  L. Calzà,et al.  Hyperforin down‐regulates effector function of activated T lymphocytes and shows efficacy against Th1‐triggered CNS inflammatory‐demyelinating disease , 2008, Journal of leukocyte biology.

[24]  C. Berking,et al.  Photodynamic therapy with BF‐200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer‐blind phase III study in comparison with a registered methyl‐5‐aminolaevulinate cream and placebo , 2012, The British journal of dermatology.

[25]  R. Tackett,et al.  Effect of St. John's wort on free radical production. , 2001, Life sciences.

[26]  B. Chernov,et al.  [Structure of the chromophoric part of hyperforin]. , 1975, Doklady Akademii nauk SSSR.

[27]  J. Heilmann,et al.  Studies on the Antioxidative Activity of Phloroglucinol Derivatives Isolated from Hypericum Species , 2003, Planta medica.

[28]  А.А. Джиджоева,et al.  Ointment for the treatment of burns , 1996 .

[29]  D. Secci,et al.  Efficacy of Hypericum and Calendula oils in the epithelial reconstruction of surgical wounds in childbirth with caesarean section. , 2001, Farmaco.

[30]  Jeffrey D. Neighbors,et al.  Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents , 2009, Pharmaceutical biology.

[31]  B. Bauvois,et al.  Hyperforin Inhibits Akt1 Kinase Activity and Promotes Caspase-Mediated Apoptosis Involving Bad and Noxa Activation in Human Myeloid Tumor Cells , 2011, PloS one.

[32]  C. D. Miller,et al.  Investigating the Effectiveness of St John's Wort Herb as an Antimicrobial Agent against Mycobacteria , 2012, Phytotherapy research : PTR.

[33]  S. Martín-Aragón,et al.  Antioxidant properties and protective effects of a standardized extract of Hypericum perforatum on hydrogen peroxide-induced oxidative damage in PC12 cells. , 2004, Life sciences.

[34]  S. Nonell,et al.  On the mechanism of Candida spp. photoinactivation by hypericin , 2012, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[35]  Taeck-Hyun Lee,et al.  Protective effect of Hypericum perforatum Linn (St. John's wort) against hydrogen peroxide-induced apoptosis on human neuroblastoma cells , 2002, Neuroscience Letters.

[36]  S. Onoue,et al.  In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts. , 2011, Phytochemistry.

[37]  R. Saller,et al.  A current review of the antimicrobial activity of Hypericum perforatum L. , 2001, Pharmacopsychiatry.

[38]  D. Wei,et al.  Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro. , 2004, Journal of agricultural and food chemistry.

[39]  A. Bilia,et al.  Analysis and stability of the constituents of St. John's wort oils prepared with different methods. , 2007, Journal of pharmaceutical and biomedical analysis.

[40]  P. Beattie,et al.  Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's Wort supplements and high dose UVA-1 therapy. , 2005, Toxicology letters.

[41]  J. Simon,et al.  Topical treatment of atopic dermatitis with St. John's wort cream--a randomized, placebo controlled, double blind half-side comparison. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[42]  Wolf-Henning Boehncke,et al.  Reduced TRPC Channel Expression in Psoriatic Keratinocytes Is Associated with Impaired Differentiation and Enhanced Proliferation , 2011, PloS one.

[43]  S. Gibbons,et al.  The genus Hypericum--a valuable resource of anti-Staphylococcal leads. , 2002, Fitoterapia.

[44]  Kathleen Delate,et al.  Identification of light-independent inhibition of human immunodeficiency virus-1 infection through bioguided fractionation of Hypericum perforatum , 2009, Virology Journal.

[45]  P. Najafizadeh,et al.  The evaluation of the clinical effect of topical St Johns wort (Hypericum perforatum L.) in plaque type psoriasis vulgaris: A pilot study , 2012, The Australasian journal of dermatology.

[46]  Alexander H Schmidt Use of an on-line, precolumn photochemical reactor in high-performance liquid chromatography of naphthodianthrones in Hypericum perforatum preparations. , 2003, Journal of chromatography. A.

[47]  O. Werz,et al.  Hyperforin, an Anti-Inflammatory Constituent from St. John's Wort, Inhibits Microsomal Prostaglandin E2 Synthase-1 and Suppresses Prostaglandin E2 Formation in vivo , 2010, Front. Pharmacol..

[48]  E. Lima,et al.  Comparison of the endemic Azorean Hypericum foliosum with other Hypericum species: antioxidant activity and phenolic profile , 2011, Natural product research.

[49]  Y. Oztürk,et al.  Wound-healing activity of St. John's Wort (Hypericum perforatum L.) on chicken embryonic fibroblasts. , 2007, Journal of ethnopharmacology.

[50]  R. Lüdtke,et al.  Topical application of St John’s wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells , 2000, The British journal of dermatology.

[51]  M C Meinke,et al.  Enhancement of skin radical scavenging activity and stratum corneum lipids after the application of a hyperforin-rich cream. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[52]  Shiow-Ling Lee,et al.  Effect of Topical Application of Chlorogenic Acid on Excision Wound Healing in Rats , 2013, Planta Medica.

[53]  Z. Saddiqe,et al.  A review of the antibacterial activity of Hypericum perforatum L. , 2010, Journal of ethnopharmacology.

[54]  R. Lüdtke,et al.  Effect of topical application of Hypericum perforatum extract (St. John's wort) on skin sensitivity to solar simulated radiation , 2000, Photodermatology, photoimmunology & photomedicine.

[55]  K. Kovar,et al.  Analysis and Stability of Hyperici Oleum , 1992, Planta medica.

[56]  J. J. van den Oord,et al.  Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin , 2007, The British journal of dermatology.

[57]  F. Dajas Life or death: neuroprotective and anticancer effects of quercetin. , 2012, Journal of ethnopharmacology.

[58]  A. Rosato,et al.  Extracts from St John's wort and their antimicrobial activity , 2004, Phytotherapy research : PTR.

[59]  E. Akkol,et al.  Investigations on the in vivo wound healing potential of Hypericum perforatum L. , 2010, Journal of ethnopharmacology.

[60]  D. Wyse,et al.  Antimicrobial activity of native and naturalized plants of Minnesota and Wisconsin. , 2008 .

[61]  Lenka Dzurová,et al.  Cell death response of U87 glioma cells on hypericin photoactivation is mediated by dynamics of hypericin subcellular distribution and its aggregation in cellular organelles , 2012, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[62]  Zheng Huang,et al.  Hypericin‐mediated Photodynamic Antimicrobial Effect on Clinically Isolated Pathogens † , 2012, Photochemistry and photobiology.

[63]  L. Davids,et al.  Hypericin‐PDT‐induced rapid necrotic death in human squamous cell carcinoma cultures after multiple treatment , 2012, Cell biology international.

[64]  J. Schulte‐Mönting,et al.  Single-dose and steady-state administration of Hypericum perforatum extract (St John's Wort) does not influence skin sensitivity to UV radiation, visible light, and solar-simulated radiation. , 2001, Archives of dermatology.

[65]  C. Schempp,et al.  Skin Tolerance of a New Bath Oil Containing St. John’s Wort Extract , 2008, Skin Pharmacology and Physiology.

[66]  Sabine Schanzer,et al.  In vivo photoprotective and anti-inflammatory effect of hyperforin is associated with high antioxidant activity in vitro and ex vivo. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[67]  C. Crumpacker,et al.  Phase I Studies of Hypericin, the Active Compound in St. John's Wort, as an Antiretroviral Agent in HIV-Infected Adults: AIDS Clinical Trials Group Protocols 150 and 258 , 1999, Annals of Internal Medicine.

[68]  D. Kacerovská,et al.  Photodynamic Therapy of Nonmelanoma Skin Cancer with Topical Hypericum perforatum Extract—A Pilot Study , 2008, Photochemistry and photobiology.

[69]  P. Dixon,et al.  Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compounds. , 2006, Journal of photochemistry and photobiology. B, Biology.

[70]  J. Simon,et al.  Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria , 1999, The Lancet.

[71]  S. Vittori,et al.  Phytochemical and antioxidant analysis of eight Hypericum taxa from Central Italy. , 2008, Fitoterapia.

[72]  D. Romagnolo,et al.  Flavonoids and Cancer Prevention: A Review of the Evidence , 2012, Journal of nutrition in gerontology and geriatrics.

[73]  J. Simon,et al.  Phototoxic and Apoptosis-Inducing Capacity of Pseudohypericin , 2002, Planta medica.

[74]  F. A. Andersen Final Report on the Safety Assessment of Hypericum Perforatum Extract and Hypericum Perforatum Oil , 2001, International journal of toxicology.

[75]  P. Dixon,et al.  Inhibition of prostaglandin E(2) production by anti-inflammatory hypericum perforatum extracts and constituents in RAW264.7 Mouse Macrophage Cells. , 2007, Journal of agricultural and food chemistry.

[76]  A. Riva,et al.  Topical anti‐inflammatory activity of extracts and compounds from Hypericum perforatum L. , 2007, The Journal of pharmacy and pharmacology.

[77]  M. Baptista,et al.  Local clinical phototreatment of herpes infection in São Paulo. , 2012, Photodiagnosis and Photodynamic Therapy.

[78]  J. Lademann,et al.  Radical protection in the visible and infrared by a hyperforin‐rich cream – in vivo versus ex vivo methods , 2013, Experimental dermatology.

[79]  C. Borner,et al.  Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis , 2002, Oncogene.

[80]  W. Merlevede,et al.  Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. , 1998, Anticancer research.

[81]  J. Sleeman,et al.  Hyperforin acts as an angiogenesis inhibitor. , 2005, Planta medica.